简化国际膀胱癌工作组中危非肌层浸润性膀胱癌分层:三因素方法
多中心回顾性分析2822例接受经尿道膀胱肿瘤电切术及膀胱内治疗的中危非肌层浸润性膀胱癌患者,多变量Cox回归仅多灶性、早期复发和膀胱内治疗失败独立预测肿瘤学结局。基于这三因素构建的简化模型将患者分为低危(无因素)、中危(1个因素)和高危(≥2个因素),其区分能力与完整IBCG五因素模型相当,无显著判别损失。
要点
- 仅多灶性、早期复发和膀胱内治疗失败独立预测中危NMIBC的复发与进展。
- 简化三因素模型将患者分为低危(0因素)、中危(1因素)、高危(≥2因素)。
- 简化模型与完整IBCG模型判别能力相当,无显著损失。
核心结论
- 三个变量捕获了该队列中大部分预后信息,与完整模型相比无判别能力损失。
- 简化模型为内部验证的改进,计划外部验证以确认通用性并确保简化阈值不改变临床重要的中危-高危亚组。
研究设计与样本
- 多中心回顾性分析,纳入2005年至2025年间接受经尿道膀胱肿瘤电切术和膀胱内治疗的2822例中危NMIBC患者。
- 使用多变量Cox回归识别独立预测因素,构建简化风险模型并与完整IBCG五因素模型比较。
主要发现
- 完整IBCG模型分类:中危-低危1143例(41%),中危-中危1535例(54%),中危-高危144例(5%)。
- 多变量分析显示仅多灶性、早期复发和膀胱内治疗失败独立预测肿瘤学结局。
- 简化模型分类:中危-低危1535例(54%),中危-中危906例(32%),中危-高危381例(14%)。
- 简化风险组的3年复发率和进展率呈逐步升高趋势。
- 简化模型在所有指标上的区分性能与完整模型相当,无显著判别损失。
关键数值与推荐
- 简化模型风险分层:无因素为中危-低危,1个因素为中危-中危,≥2个因素为中危-高危。
- 完整IBCG模型风险分层:中危-低危41%,中危-中危54%,中危-高危5%。
临床怎么用
- 简化三因素模型可用于中危NMIBC的风险分层,减少评估复杂度。
- 简化模型可能辅助临床决策,但需外部验证确认其通用性及对中危-高危亚组的影响。
局限性
- 回顾性研究设计。
- 简化模型仅为内部验证,需外部验证确认通用性。
- 简化阈值可能改变临床重要的中危-高危亚组,需进一步确保。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate whether a simplified risk model preserves the prognostic performance of the International Bladder Cancer Group (IBCG) five-factor risk stratification model in intermediate-risk (IR) non-muscle-invasive bladder cancer (NMIBC). PATIENTS AND METHODS: We performed a multicentre retrospective analysis of 2822 patients with IR NMIBC treated with transurethral resection of bladder tumour and intravesical therapy between 2005 and 2025. Multivariable Cox regression identified independent predictors of recurrence and progression. A simplified risk model was constructed using significant variables and compared with the full IBCG model using recurrence and progression rates, area under the curve analysis, and likelihood ratio testing. RESULTS: A total of 2822 patients with IR NMIBC were included. When classified using the full IBCG model, 1143 (41%) were in the IR-low, 1535 (54%) IR-intermediate, and 144 (5%) IR-high-risk groups. On multivariable analysis, only multifocality, early recurrence, and failure of intravesical therapy independently predicted oncological outcomes. Using these factors, patients were stratified as IR-low (no factors), IR-intermediate (one factor), or IR-high (two or more factors). Under the simplified model, 1535 (54%) patients were classified as IR-low, 906 (32%) as IR-intermediate, and 381 (14%) as IR-high. The 3-year recurrence and progression rates increased stepwise across simplified risk groups. Discriminative performance of the simplified model was comparable to the full model across all metrics, with no meaningful loss of discrimination. CONCLUSION: Three variables captured the most prognostic signal in this cohort without loss of discrimination compared with the full model. This simplified model is an internally validated refinement, with planned external validation to confirm generalisability and to ensure that simplified thresholds do not alter the clinically important IR-high subgroup used in care and trials.
引用
- Siva J, Aydogdu C, Heller N, et al. Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approach. BJU Int. 2026. PMID: 41924954. doi:10.1111/bju.70269
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。